NCT00727519

Brief Summary

Pomegranate juice (PJ) consumption by hemodialysis patients will reduce the oxidative stress and the incidence of infections, cardiovascular events and mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jul 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2008

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

July 27, 2008

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 4, 2008

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2010

Completed
Last Updated

March 23, 2010

Status Verified

March 1, 2010

First QC Date

July 27, 2008

Last Update Submit

March 22, 2010

Conditions

End Stage Renal DiseaseHemodialysis

Keywords

HemodialysisNephrologyPomegranate JuiceIsrael

Study Arms (2)

PG

EXPERIMENTAL
Dietary Supplement: Pomegranate juice

PL

EXPERIMENTAL
Dietary Supplement: Placebo

Interventions

Pomegranate juiceDIETARY_SUPPLEMENT
PG
PlaceboDIETARY_SUPPLEMENT
PL

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • End Stage Renal Disease, stable chronic hemodialysis \> 3 months
  • Informed Consent.
  • Man and women over 18 years.

You may not qualify if:

  • Hemodialysis \< 3 months
  • Participation in other clinical trial
  • Not eligible according to physician decision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Western Galilee hospital

Nahariya, Israel, 22100, Israel

Location

Related Publications (1)

  • Shema-Didi L, Kristal B, Sela S, Geron R, Ore L. Does Pomegranate intake attenuate cardiovascular risk factors in hemodialysis patients? Nutr J. 2014 Mar 4;13:18. doi: 10.1186/1475-2891-13-18.

    PMID: 24593225DERIVED

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 3
Purpose
PREVENTION
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

July 27, 2008

First Posted

August 4, 2008

Study Start

July 1, 2008

Study Completion

January 1, 2010

Last Updated

March 23, 2010

Record last verified: 2010-03

Locations

IL(1)